Bicaudal D Homolog 2 (BICD2) (Middle Region) Peptid
BICD2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BICD2 Produkte
- BICD2 (Bicaudal D Homolog 2 (BICD2))
- Protein Region
- Middle Region
- Spezies
- Human
- Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SLSEQQEKVT RLTENLSALR RLQASKERQT ALDNEKDRDS HEDGDYYEVD
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BICD2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BICD2 (Bicaudal D Homolog 2 (BICD2))
- Hintergrund
-
This gene is one of two human homologs of Drosophila bicaudal-D and a member of the Bicoid family. It has been implicated in dynein-mediated, minus end-directed motility along microtubules. It has also been reported to be a phosphorylation target of NIMA related kinase 8. Two alternative splice variants have been described.
Alias Symbols: BICD2,KIAA0699,
Protein Size: 824 - Gen-ID
- 23299
- NCBI Accession
- NP_056065
- UniProt
- Q8TD16
-
Sie sind hier:
